Clinical Trial Update: Neoadjuvant Treatment of Fruquintinib Combined With Concurrent Chemoradiotherapy for LARC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating neoadjuvant Fruquintinib combined with concurrent chemoradiotherapy for locally advanced rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)

Snippet

Sponsor: Henan Provincial People's Hospital | Conditions: Rectal Cancer | Phase 2 | Status: UNKNOWN